Drobinski, P.J.; Nissen, N.I.; Sinkeviciute, D.; Willumsen, N.; Karsdal, M.A.; Bay-Jensen, A.C.
In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker. Int. J. Mol. Sci. 2023, 24, 321.
https://doi.org/10.3390/ijms24010321
AMA Style
Drobinski PJ, Nissen NI, Sinkeviciute D, Willumsen N, Karsdal MA, Bay-Jensen AC.
In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker. International Journal of Molecular Sciences. 2023; 24(1):321.
https://doi.org/10.3390/ijms24010321
Chicago/Turabian Style
Drobinski, Patryk J., Neel I. Nissen, Dovile Sinkeviciute, Nicholas Willumsen, Morten A. Karsdal, and Anne C. Bay-Jensen.
2023. "In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker" International Journal of Molecular Sciences 24, no. 1: 321.
https://doi.org/10.3390/ijms24010321
APA Style
Drobinski, P. J., Nissen, N. I., Sinkeviciute, D., Willumsen, N., Karsdal, M. A., & Bay-Jensen, A. C.
(2023). In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker. International Journal of Molecular Sciences, 24(1), 321.
https://doi.org/10.3390/ijms24010321